This brand name is authorized in Nigeria.
The drug VAROXA contains one active pharmaceutical ingredient (API):
1
|
UNII
9NDF7JZ4M3 - RIVAROXABAN
|
|
Rivaroxaban is a highly selective direct factor Xa inhibitor with oral bioavailability. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-100765 | Tablet | VAROXA 10 Tablets TAB 10 mg 3x10 | 13 NF-PP-397239 VAROXA 10 Tablets Rivaroxaban 10mg Active: RIVAROXABAN 10mg List of excipients: Microcrystalline cellulose Lactose monohydrate Croscarmellose sodium Hypromellose Sodium lauryl sulphate Magnesium stearate Opadry Pink 03F540164 Hypromellose, Titanium dioxide, Macrogol, Hypromellose, Iron Oxide red A4-100765 Drugs Imported Products 3x10 POM 1 12/21/2023 MICRO NOVA PHARMACEUTICALS IND. LTD, PLOT 3, BILLINGS WAY, INDUSTRIAL ESTATE, IKEJA IKEJA LAGOS 81299901 solomonsemicrolabs@gmail.com M/S MICRO LABS LIMITED., 92, SIPCOT IND. COMPLEX HOSUR 635126 INDIA, India | 28/02/2024 |
| A4-100766 | Tablet | VAROXA 20 Tablets TAB 20 mg 3x10 | 14 NF-PP-397271 VAROXA 20 Tablets Rivaroxaban 20mg Active: Rivaroxaban 20mg. List of excipients: Microcrystalline cellulose Lactose monohydrate Croscarmellose sodium Hypromellose Sodium lauryl sulphate Magnesium stearate Opadry Brown 03F565106 Hypromellose, Titanium dioxide, Macrogol, Iron Oxide red A4-100766 Drugs Imported Products 3x10 POM 1 12/21/2023 MICRO NOVA PHARMACEUTICALS IND. LTD, PLOT 3, BILLINGS WAY, INDUSTRIAL ESTATE, IKEJA IKEJA LAGOS 81299901 solomonsemicrolabs@gmail.com M/S MICRO LABS LIMITED., 92, SIPCOT IND. COMPLEX HOSUR 635126 INDIA, India | 28/02/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B01AF01 | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AF Direct factor Xa inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-100765, A4-100766 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.